Literature DB >> 15897372

Hyperleptinemia: protecting the heart from lipid overload.

Roger H Unger1.   

Abstract

In this review, we attempt to deduce teleologically the physiological mission of leptin. Because overnutrition and diet-induced obesity are the only known causes of hyperleptinemia, we contrast the differences in overnutrition in normally leptinized rodents, in which the added lipids are confined to adipocytes, with those of unleptinized rodents, in which the added lipids are distributed in liver, pancreatic islets, and heart and skeletal muscle, causing organ dysfunction and cell death with a disease cluster resembling metabolic syndrome. We focus here on lipid-induced cardiac dysfunction and the remarkable ability of hyperleptinemia to prevent it. We conclude that the hyperleptinemia of overnutrition prevents the ectopic lipid deposition by: (1) acting on hypothalamic appetite centers to limit the caloric surplus to fit the available adipocyte storage capacity and, (2) upregulating of fatty acid oxidation and downregulating lipogenesis in peripheral tissues to minimize ectopic lipid deposition. The causes of failure of this system and its clinical consequences are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897372     DOI: 10.1161/01.HYP.0000165683.09053.02

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  35 in total

1.  Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia.

Authors:  Ronghua Yang; Gautam Sikka; Jill Larson; Vabren L Watts; Xiaolin Niu; Carla L Ellis; Karen L Miller; Andre Camara; Christian Reinke; Vladimir Savransky; Vsevolod Y Polotsky; Christopher P O'Donnell; Dan E Berkowitz; Lili A Barouch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-28       Impact factor: 4.733

Review 2.  The metabolic syndrome and the heart--a considered opinion.

Authors:  J G Leichman; V R Lavis; D Aguilar; C R Wilson; H Taegtmeyer
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

3.  Effects of leptin on cardiovascular physiology.

Authors:  Johnathan D Tune; Robert V Considine
Journal:  J Am Soc Hypertens       Date:  2007 Jul-Aug

Review 4.  Adaptation and maladaptation of the heart in obesity.

Authors:  Romain Harmancey; Christopher R Wilson; Heinrich Taegtmeyer
Journal:  Hypertension       Date:  2008-06-23       Impact factor: 10.190

5.  Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction.

Authors:  Monika K Duda; Karen M O'Shea; Biao Lei; Brian R Barrows; Agnes M Azimzadeh; Tracy E McElfresh; Brian D Hoit; Willem J Kop; William C Stanley
Journal:  J Card Fail       Date:  2008-05       Impact factor: 5.712

6.  Association of serum leptin with future left ventricular structure and function: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Shishir Sharma; Laura A Colangelo; Matthew A Allison; Joao A C Lima; Bharath Ambale-Venkatesh; Satoru Kishi; Kiang Liu; Philip Greenland
Journal:  Int J Cardiol       Date:  2015-05-14       Impact factor: 4.164

7.  Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone.

Authors:  Alexander Kokkinos; Iordanis Mourouzis; Despoina Kyriaki; Constantinos Pantos; Nicholas Katsilambros; Dennis V Cokkinos
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

Review 8.  Is the metabolic syndrome a real clinical entity and should it receive drug treatment?

Authors:  Tamara Darsow; David Kendall; David Maggs
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 9.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

10.  Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation.

Authors:  Michael E Hall; Matthew W Maready; John E Hall; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-17       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.